• Tuberculosis and Respiratory Diseases
• /
• v.64 no.2
• /
• pp.95-101
• /
• 2008

Background: Drug resistant tuberculosis (TB) in patients who have not received previous TB treatment (initial drug resistance) is a serious problem for the control of TB. However, prevalence of initial drug resistance among pulmonary TB patients has not been well characterized in Korea, especially in the private sector. We assessed the prevalence of initial drug resistance and evaluated the risk factors for drug resistance in pulmonary TB patients, at a regional tertiary hospital in Cheonan. Methods: We performed a drug susceptibility test for both first and second line anti-TB drugs in all culture-confirmed pulmonary TB patients who had not received a previous TB treatment at Dankook University Hospital from September 2005 to September 2007. In addition, we evaluated the initial drug resistance pattern and clinical characteristics of patients to evaluate the risk factors for initial drug resistance. We also assessed the influence of the drug susceptibility test results on the treatment regimen. Results: Of the total 156 cases where the drug susceptibility test was performed, resistance to at least one anti-TB drug was found in 21 cases (15.6%) and multidrug resistance, where TB was resistant to at least isoniazid and rifampin, was found in one case (0.6%). Multivariate logistic regression showed no clinical characteristics were independently associated with initial drug resistance. Of the total 156 patients who underwent the drug susceptibility test, the treatment regimen was changed for 15 patients (9.6%) according to the results of the drug susceptibility test. Conclusion: Initial drug resistance is common and the drug susceptibility test is informative for pulmonary TB patients who have not received previous TB treatment.

• Journal of Yeungnam Medical Science
• /
• v.13 no.1
• /
• pp.11-21
• /
• 1996

항암치료에 있어 내성기전은 암세포의 종류에 따라 다양하며 동일세포라도 내성이 생긴 항암제에 따라 그 기능이 다른 것으로 보고되고 있으며 세포종류 및 항암제에 따른 각각의 내성기전을 완전히 알기란 그리 쉬운 일이 아니다. 그러나 임상치료에 있어서 항암제의 적용은 대개 내성 생성이 잘 안되는 즉 교차내성이 적게 일어나는 약제끼리의 선택이 화학요법에 유리하며 재발방지의 지표가 될 수 있으며 내성억제가 가능한 약제의 개발이 중요하다. 또 암에 따른 정확한 내성기전을 잘 밝힘으로서 내성을 방지할 수 있는 target 약제를 함께 병용 개발하는 것이 암의 치료의 지름길이 될 수 있다.

• Korean Journal of Veterinary Research
• /
• v.19 no.2
• /
• pp.121-126
• /
• 1979

대장균 설사중에 걸린 어린 돼지, 송아지, 어린 양에서 분리한 대장균 126주의 항생제와 화학요법제(15종)에 대한 감수성을 disc diffusion technique로 조사한 성적은 다음과 같다. 1. 어린 돼지에서 분리한 62주의 대장균은 gentamicin(GM)에 100%, colistin(CL)에 96.8%, kanamycin(KM)에 93.5%, neomycin(NM)에는 91.9%가 감수성을 가지고 있었으나 ampicillin(AM), erythromycin(EM), lincomycin (LM), novobiocin (NB), penicillin (PC), streptomycin(SM), tetracycline(TC), sulfaisodimidin(SU)에는 내성을 가지고 있었다. chloramphenicol(CP), sulfamethoxazole-trimethoprim(SXT), cephalosporin(CE)에는 각각 75.8%, 64.5%, 50%가 감수성이 있었다. 2. 송아지에서 분리한 32주의 대장균은 GM에 100%, CL에는 87.5%, SXT에는 66.7%가 감수성이 있었으나 CP와 KM에는 각각 40.6%, SU에는 56.2% NM에는 62.5%, SM에는 87.5%가 내성을 가지고 있었다. EM, LM, NB, PC에는 전혀 감수성이 없었으며 AM, SM, TC에도 고도의 내성을 가지고 있었다. 3. 어린 양에서 분리한 32주의 대장균은 GM과CL에 100%, CP에 96.9%, KM과 NM에 90.6%가 감수성이 있었다. SM과 SU에도 71.9%나 감수성이 있었으나 CM, EM, LM, PC, TC에는 대부분 내성을 가지고 있었다. AM에는 21.9%가 감수성이 있었다. 4. 2종류 이상의 약제에 내성을 가진 대장균의 AM, CE, CP, CL, GM, KM, NM. SM, TC, SU등 10종의 약제에 대한 multiple drug resistance pattern(MDRP)을 조사한 바 돼지 유래 약제내성 대장균의 MDRP는 18가지였으며 이중 가장 빈도가 높은 것은 AM, CE, SM, TC, SU 내성형으로 전체의 24.2%나 되었다. 송아지 유래 약제내성 대장균의 MDRP는 17가지였으며, AM, CE, CP, KM, NM, SM, TC, SU 내성형이 28.1%로 가장 빈도가 높았다. 반면에 어린 양에서 분리한 대장균의 MDRP는 9가지였으며 AM, CE, SU의 3약제 내성형이 40.6%로 가장 많았다.

• The Journal of the Korean Society for Microbiology
• /
• v.12 no.1
• /
• pp.11-18
• /
• 1977

A total of 665 strains of Escherichia coli isolated in Korea from stools of patients who were treated with antimicrobial drugs, doctors, and students were tested for the drug resistance and distribution of R plasmids. Approximately 25 to 41% of isolates were resistant to chloramphenicol, tetracycline, streptomycin, sulfisemidine and ampicillin(AP), and 9.5% were resistant to kanamycin. Nalidixic acid-resistant strains were only rarely encountered. The prevalence of resistant strains was significantly higher among patients than doctors and students. Strains multiply resistant to four or more drugs were significantly more prevalent among patient isolates than those from doctors and students, while no difference on the incidence of strains resistant to three or less drugs was noted among isolates from the three groups. The persons carrying strains resistant to four or more drugs were more frequently found among patients than doctors and students. Quite large proportions of drug-resistant strains transferred their resistance to drug-sensitive E. coli, with frequent transfer of whole resistance and AP resistance. Strains having higher multiplicity of resistance showed a tendency toward higher incidence of resistance transfer, irrespective of the origins of strains.

• The Journal of the Korean Society for Microbiology
• /
• v.21 no.4
• /
• pp.461-471
• /
• 1986

Shigella strains isloated in the Teagu area during the period from 1973 to 1985 were studied for species distribution, drug resistance, and R plasmids. Approximately 1,200 strains were isolated during this period, and most of them were classified into Shigella flexneri, S. sonnei occupied less than 20%, and S. dysenteriae and S. boydii were very rarely isolated. More than 95% of them were resistant to one or more of these drugs; chloramphenicol (Cm), tetracycline (Tc), streptomycin (Sm), sulfisomidine (Su), ampicillin (Ap), and trimethoprim (Tp). Strains resistant to kanamycin, nalidixic acid (Na), and rifampin (Rf) were rare, and no strain was resistant to cephaloridine, gentamicin, and amikacin. Approximately half of the isolates were resistant to drugs in 1973, but the rate of resistant strains increased to more than 95% from 1977. Strains resistant to the four drugs (Cm, Tc, Sm, and Su) occupied the majority of resistant strains until 1977, but the most prevalent multiplicity of drug resistance increased to six drugs (Cm, Tc, Sm, Su, Ap, and Tp) from 1978 with the marked increase of Ap- and Tp-resistant strains. Approximately 75% of them transferred resistance to Escherichia coli by conjugation, and the resistance was considered to be mediated by R plasmids. Almost all of them transferred the complete patterns of resistance to drugs except Na and Rf. However, among some strains of recent isolates, small numbers of segregants of transferred resistance were observed. The R plasmids in Shigella were mostly classified into Inc FII, and only small numbers into Inc B. Segregants were in most cases unclassified.

• Journal of the Korea Academia-Industrial cooperation Society
• /
• v.12 no.11
• /
• pp.5012-5018
• /
• 2011

According to the nationwide survey of tuberculosis from 1965 to 1995, the incidence and drug resistance rate of tuberculosis have been decreased in Korea, but the prevalence of multidrug resistance of Mycobacterium tuberculosis is still a serious problem. The purpose of this study is to investigate the drug resistance rate and pattern of tuberculosis in Daejeon from 2001 to 2008. Of the total 581cases where the drug susceptibility test was performed, resistance to at least one anti-TB drug was found in 104 cases(17.9%) of these, 68(11.7%) were resistant to at least INH and 41(7.1%) were resistant to at least RFP. Single-drug resistance was found for isolates from 37(6.4%) ; 18(3.1%) of these were resistant to INH and 5(0.9%) to RFP. Multidrug resistance, where TB was resistant to at least isoniazid and refampin, was found in 35 cases(6.0%). and Factors associated with MDR-TB included age under 40-60.The drug-resistance rate of pulmonary TB, especially MDR-TB, is higher in the initial treated patients at a private referral hospital than in those in the pubulic sector. Initial drug resistance is common and the drug susceptibility test is informative for pulmonary TB patients who have not received previous TB treatment. The need for an improved control program, coupled with early diagnosis of MDR-TB, to reduce the spread and development of resistance. Multidrug resistance rate is still problem in korea. Efforts to decrease multidrug resistance rate either independently or in cooperation with the pubulic sector will be needed.

• Tuberculosis and Respiratory Diseases
• /
• v.42 no.6
• /
• pp.831-837
• /
• 1995

Background: We conducted a study to determine the factors associated with, patterns of, and proportion of cases of pulmonary tuberculosis with multiple drug-resistance at Kosin medical center in Pusan. Methods: We abstracted data from 141 patients, who had active pulmonary tuberculosis and report forms of drug susceptibility between 1986 and 1994, and related the previous treatment history, the extent of lung involvement and the presence of cavities on chest X-ray films to the drug resistance. Results: Overall, 59(41.8%) of the 141 cases of tuberculosis were resistant to at least one drug and 29(20.9%) of the 139 cases were resistant to isoniazid(INH) and rifampin(RIF). Among the 63 patients with previous tuberculosis therapy, 40(63.5%) had isolates that were drug-resistant and 24(38.1%) were multi-drug resistant. Among the 78 without previous therapy, 19(24.4%) had isolates that were drug-resistant and 5(7.5%) were multi-drug resistant. For all 141, resistance to INH was most common(39.0%) followed by RIF(21.6%), ethambutol(EMB, 16.3%), $\rho$- aminosalicylic acid(10.8%), streptomycin(SM, 8.7%), and pyrazinamide(PZA, 8.0%). INH, RIF and PZA resistances were independently associated with a history of previous tuberculosis therapy (odds ratio; 3.3, 7.2 and 10.8 respectively), and RIF and SM resistance were significantly high according to the extent of lung involvement on the chest films(odds ratio; 2.9 and 2.8 respectively). Conclusions: We conclude, (1) that all persons in whom pulmonary tuberculosis is diagnosed should initially receive at least four-drug therapy(INH, RIF, PZA, and EMB or SM), (2) that susceptibility testing be done in all culture-positive patient, and (3) that those with a history of previous tuberculosis therapy or those who have advanced pulmonary tuberculosis need very careful clinical and microbiological follow-up.

• Tuberculosis and Respiratory Diseases
• /
• v.59 no.6
• /
• pp.619-624
• /
• 2005

Background : The drug resistance rate in tuberculosis patients with history of chemotherapy is an important indicator of for evaluation of appropriateness of treatment regimens and compliance of patients. This study examined the long-term changes in the drug resistance rates among TB patients failed in treatment or reactivated. Methods : The results of drug susceptibility testing data from patients registered in health centers from 1981 to 2004 were analyzed. Results : The rate of resistance to isoniazid decreased from 90% to 20%, and the resistance to ethambutol decreased from 45% to 6%. The rate of resistance to rifampicin varied from 13% to 28% and the resistance to pyrazinamide was 5% to 10%. Multidrug resistance was about 2-3% lower than any rifampicin resistance rates. The second-line drug resistance was ranged from 1% to 3%. There was no difference between patients' genders. Patient numbers per 100,000 population increased with age. The regional distribution was even at 4-6 patients per 100,000 population, and drug resistance rates were significantly lower in big city areas than in small towns and rural areas. Conclusion : The rates of resistance of Mycobacterium tuberculosis isolated from TB patients with history of chemotherapy to isoniazid, rifampin, ethambutol, and isoniazid plus rifampin were significantly decreased during over two decades.

• The Journal of the Korean Society for Microbiology
• /
• v.13 no.1
• /
• pp.7-16
• /
• 1978

One hundred and three clinical isolates of enterococci were examined for susceptibility to 8 antibiotics, and transferability and transfer frequency of R plasmid. Ampicillin was the most active, followed in decreasing order by rifampin, amikacin and chloramphenicol, and tetracycline. High-level resistance(${\geq}2,000{\mu}g/ml$) to kanamycin, streptomycin, and gentamicin, known as the most active of the aminoglycosides to enterococcus, was present in 26.2%, 21.4%, and 18.3% of the isolates, respectively. In the drug susceptibility of the species, S. zymogenes was the most resistant and S. durans was the most sensitive to tested antibiotics. We could observed the transferability of enterococcal R plasmid in mixed culture: among the 28 strains which showed multiple drug resistance, 17 strains transferred all or part of their resistance with $2{\times}10^{-4}-2{\times}10^{-6}%$ of transfer frequency to a plasmid-free recipient, S. faecalis strain JH 2-2.

• Journal of fish pathology
• /
• v.12 no.2
• /
• pp.115-121
• /
• 1999

MIC test of 16 chemotherapeutic agents was performed on 24 isolates of Edwardsiella tarda collected from flounders. They revealed resistance against combinations of ampicillin, amoxicillin, erythromycin, flumequine, doxycycline(DOXY), nalidixic acid, novobiocin, oxolinic acid, oxytetracycline(OTC), thiamphenicol(TP) and sulfonamide. Two strains carried transferable R plasmid encoding Otc Kanamycin Tp and Otc chloramphenicol Doxy Tetracycline Tp, respectively. The R plasmids were not similar each other on the basis of their digestion pattern of restriction endonuclease, suggesting distribution of different transferable R plasmid among E. tarda from flounders.